
LifeMD (LFMD) Stock Forecast & Price Target
LifeMD (LFMD) Analyst Ratings
Bulls say
LifeMD is positioned for long-term success due to their comprehensive platform and expansion into high-demand areas like Women's Health and Dermatology. With their use of AI technology and strong financial standing, they are well-equipped to continue their growth and meet increasing demand. Their unique approach and alignment with popular brands also sets them apart from competitors and mitigates regulatory risk.
Bears say
LifeMD is a direct-to-patient healthcare company in a highly competitive and regulated market, and its strategies may not work as intended. The company's current valuation of EV / 9.9x 2027E EBITDA is high compared to its projected revenue growth and potential risks such as cybersecurity threats, product recalls, and dependence on third-party suppliers. The potential for dilution due to the company's young and growing nature and uncertainty surrounding COVID-19 may also hinder the achievement of the 12-month price target of $10 based on a comparable universe analysis.
This aggregate rating is based on analysts' research of LifeMD and is not a guaranteed prediction by Public.com or investment advice.
LifeMD (LFMD) Analyst Forecast & Price Prediction
Start investing in LifeMD (LFMD)
Order type
Buy in
Order amount
Est. shares
0 shares